PT980254E - Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral - Google Patents
Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viralInfo
- Publication number
- PT980254E PT980254E PT98925588T PT98925588T PT980254E PT 980254 E PT980254 E PT 980254E PT 98925588 T PT98925588 T PT 98925588T PT 98925588 T PT98925588 T PT 98925588T PT 980254 E PT980254 E PT 980254E
- Authority
- PT
- Portugal
- Prior art keywords
- viral
- glycyclic
- comprehending
- acid
- pharmaceutical composition
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 2
- 239000002253 acid Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI001119A IT1291366B1 (it) | 1997-05-14 | 1997-05-14 | Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT980254E true PT980254E (pt) | 2002-07-31 |
Family
ID=11377123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98925588T PT980254E (pt) | 1997-05-14 | 1998-05-06 | Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6329339B1 (en:Method) |
| EP (1) | EP0980254B1 (en:Method) |
| JP (2) | JP2001525814A (en:Method) |
| KR (1) | KR100592193B1 (en:Method) |
| CN (1) | CN1114447C (en:Method) |
| AR (1) | AR012849A1 (en:Method) |
| AT (1) | ATE212232T1 (en:Method) |
| AU (1) | AU740944B2 (en:Method) |
| BG (1) | BG64748B1 (en:Method) |
| CA (1) | CA2289550A1 (en:Method) |
| CZ (1) | CZ291932B6 (en:Method) |
| DE (1) | DE69803565T2 (en:Method) |
| DK (1) | DK0980254T3 (en:Method) |
| EA (1) | EA003126B1 (en:Method) |
| ES (1) | ES2170501T3 (en:Method) |
| GE (1) | GEP20022672B (en:Method) |
| HU (1) | HU224956B1 (en:Method) |
| IL (2) | IL132651A0 (en:Method) |
| IT (1) | IT1291366B1 (en:Method) |
| PL (1) | PL189218B1 (en:Method) |
| PT (1) | PT980254E (en:Method) |
| SK (1) | SK283584B6 (en:Method) |
| TR (1) | TR199902730T2 (en:Method) |
| UA (1) | UA63955C2 (en:Method) |
| WO (1) | WO1998051334A1 (en:Method) |
| ZA (1) | ZA983917B (en:Method) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7151082B2 (en) * | 1999-02-11 | 2006-12-19 | The Feinstein Institute For Medical Research | Antagonists of HMG1 for treating inflammatory conditions |
| US6303321B1 (en) * | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
| US7304034B2 (en) | 2001-05-15 | 2007-12-04 | The Feinstein Institute For Medical Research | Use of HMGB fragments as anti-inflammatory agents |
| AU2003225073A1 (en) * | 2002-04-18 | 2003-11-03 | The University Of Iowa Research Foundation | Methods of inhibiting and treating bacterial biofilms by metal chelators |
| US7696169B2 (en) * | 2003-06-06 | 2010-04-13 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| CA2882022A1 (en) * | 2003-09-11 | 2005-03-24 | Walter Newman | Monoclonal antibodies against hmgb1 |
| WO2007011606A2 (en) * | 2005-07-18 | 2007-01-25 | Critical Therapeutics, Inc. | USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS |
| JP2009517404A (ja) * | 2005-11-28 | 2009-04-30 | メディミューン，エルエルシー | Ｈｍｇｂ１および／またはｒａｇｅのアンタゴニストならびにその使用方法 |
| IT1391170B1 (it) * | 2008-08-07 | 2011-11-18 | D M G Italia S R L | Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale |
| US9416151B2 (en) | 2010-08-25 | 2016-08-16 | Lurong ZHANG | Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis |
| CA2809031C (en) * | 2010-08-25 | 2018-10-16 | Weijian Zhang | Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis |
| EP3108894B1 (en) * | 2014-02-21 | 2022-01-26 | Kewpie Corporation | Non-therapeutic method of deactivating norovirus, use of lysozyme component for non-therapeutic norovirus deactivation, and lysozyme component for use in the prevention or treatment of norovirus infection |
| US12447166B2 (en) | 2016-02-25 | 2025-10-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
| KR102844566B1 (ko) * | 2016-02-25 | 2025-08-08 | 어플라이드 바이올로지컬 래버러토리즈 인코포레이티드 | 공기 매개 병원체 및 자극물질에 대한 보호용 조성물 및 방법 |
| CN109022351B (zh) * | 2018-09-28 | 2021-10-19 | 广州奇龙生物科技有限公司 | 重组人溶菌酶的新应用 |
| EP3928785B1 (en) * | 2020-04-27 | 2024-07-31 | Guangzhou Century Clinical Research Co., Ltd | Medicament and food for use in preventing or treating novel coronavirus pneumonia covid-19 |
| JP7543427B2 (ja) * | 2020-04-27 | 2024-09-02 | 広州新創憶薬物臨床研究有限公司 | 抗新型コロナウイルス感染症の医薬品、食品、及び使用 |
| CN112135625B (zh) * | 2020-04-27 | 2021-07-06 | 广州新创忆药物临床研究有限公司 | 一种预防或治疗covid-19新冠肺炎的药物及其应用 |
| MX2021005280A (es) | 2021-05-04 | 2022-02-23 | Spv Timser S A P I De C V | Composicion farmaceutica que contiene triterpenoides pentaciclicos. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH085800B2 (ja) * | 1986-12-19 | 1996-01-24 | エーザイ株式会社 | 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤 |
| JP2838720B2 (ja) * | 1989-10-31 | 1998-12-16 | ゼリア新薬工業株式会社 | 安定な点眼剤 |
| JP4056099B2 (ja) * | 1996-05-09 | 2008-03-05 | 森永乳業株式会社 | 水生動物の寄生生物性疾患の予防および治療剤 |
-
1997
- 1997-05-14 IT IT97MI001119A patent/IT1291366B1/it active IP Right Grant
-
1998
- 1998-05-06 AU AU77646/98A patent/AU740944B2/en not_active Ceased
- 1998-05-06 JP JP54879998A patent/JP2001525814A/ja not_active Ceased
- 1998-05-06 KR KR1019997010372A patent/KR100592193B1/ko not_active Expired - Fee Related
- 1998-05-06 ES ES98925588T patent/ES2170501T3/es not_active Expired - Lifetime
- 1998-05-06 CA CA002289550A patent/CA2289550A1/en not_active Abandoned
- 1998-05-06 SK SK1544-99A patent/SK283584B6/sk not_active IP Right Cessation
- 1998-05-06 CN CN98805037A patent/CN1114447C/zh not_active Expired - Fee Related
- 1998-05-06 IL IL13265198A patent/IL132651A0/xx active IP Right Grant
- 1998-05-06 CZ CZ19993991A patent/CZ291932B6/cs not_active IP Right Cessation
- 1998-05-06 DK DK98925588T patent/DK0980254T3/da active
- 1998-05-06 GE GEAP19985126A patent/GEP20022672B/en unknown
- 1998-05-06 WO PCT/EP1998/002797 patent/WO1998051334A1/en not_active Ceased
- 1998-05-06 HU HU0002985A patent/HU224956B1/hu not_active IP Right Cessation
- 1998-05-06 AT AT98925588T patent/ATE212232T1/de not_active IP Right Cessation
- 1998-05-06 EP EP98925588A patent/EP0980254B1/en not_active Expired - Lifetime
- 1998-05-06 TR TR1999/02730T patent/TR199902730T2/xx unknown
- 1998-05-06 US US09/423,611 patent/US6329339B1/en not_active Expired - Fee Related
- 1998-05-06 PT PT98925588T patent/PT980254E/pt unknown
- 1998-05-06 PL PL98336802A patent/PL189218B1/pl not_active IP Right Cessation
- 1998-05-06 EA EA199901024A patent/EA003126B1/ru not_active IP Right Cessation
- 1998-05-06 DE DE69803565T patent/DE69803565T2/de not_active Expired - Fee Related
- 1998-05-08 ZA ZA983917A patent/ZA983917B/xx unknown
- 1998-05-13 AR ARP980102218A patent/AR012849A1/es active IP Right Grant
- 1998-06-05 UA UA99126790A patent/UA63955C2/uk unknown
-
1999
- 1999-10-29 IL IL132651A patent/IL132651A/en not_active IP Right Cessation
- 1999-12-08 BG BG103968A patent/BG64748B1/bg unknown
-
2008
- 2008-12-25 JP JP2008331229A patent/JP2009102370A/ja not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT980254E (pt) | Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral | |
| BR9702808A (pt) | Utilização de pelo menos um retinóide apresentando uma atividade anti-ap-1 | |
| BR9504791B1 (pt) | composto de polipeptìdeo e composição farmacêutica. | |
| FI20031199A7 (fi) | Stabiileja bakterisidisia/läpäisevyyttä parantavia proteiinituotteita ja näitä sisältäviä farmaseuttisia koostumuksia | |
| IT8519353A0 (it) | Composizione farmaceutica e forme farmaceutiche che la contengono | |
| BR1100824A (pt) | Composto e composição farmacêutica | |
| ID30181A (id) | Asam antranilat- dan asam tioantranilat-n-aril amida | |
| FI944448L (fi) | Stabiloitu farmaseuttinen koostumus ja stabiloiva liuotin | |
| FI944832A7 (fi) | Farmaseuttinen koostumus | |
| BR9607317A (pt) | Peptídios e composição farmacêutica | |
| BR9607318A (pt) | Peptidos e composição farmacêutica | |
| NO20002038D0 (no) | Uløselig insulinsammensetning | |
| MX9101035A (es) | Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene | |
| ITMI962505A0 (it) | Nuovi esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono | |
| ITMI932540A0 (it) | Composizione farmaceutica | |
| PT878467E (pt) | Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos | |
| BR9509688A (pt) | Composto e composição farmacêutica | |
| IT8621393A0 (it) | Composizioni farmaceutiche ad azione vasodilatatrice e dantianossica. | |
| ID29294A (id) | Komposisi farmasi | |
| ID25857A (id) | Komposisi farmasi | |
| ES2142840T3 (es) | Proteina que se une al interferon alfa/beta, su preparacion y las composiciones farmaceuticas que la contienen. | |
| LV10579A (lv) | Farmaceitiska kompozicija | |
| ID23531A (id) | Komposisi farmasi | |
| BR9505130A (pt) | Composto e composiçao farmacêutica | |
| IT9048244A0 (it) | Composizione farmaceutica ad effetto cicatrizzante. |